Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
Nina L Wittwer,1,2 Christoph R Meier,1- 3 Carola A Huber,4 Henriette E Meyer zu Schwabedissen,1 Samuel Allemann,1,* Cornelia Schneider1,2,* 1Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; 2Hospital Pharmacy, University Hospital Basel, Basel, Switzerla...
Saved in:
Main Authors: | Wittwer NL (Author), Meier CR (Author), Huber CA (Author), Meyer zu Schwabedissen HE (Author), Allemann S (Author), Schneider C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
by: Jeiziner C, et al.
Published: (2022) -
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
by: Bollinger A, et al.
Published: (2023) -
Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
by: Jeiziner C, et al.
Published: (2021) -
Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept
by: Céline K. Stäuble, et al.
Published: (2021) -
A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
by: Céline K. Stäuble, et al.
Published: (2022)